Clinical Trial: A Clinical Study in Healthy Adults to See How the Body Processes and How Safe a Tablet That Combines Gemigliptin, Dapagliflozin, and Metformin is, Compared With Taking Zemiglo and Xigduo XR Together While Fasting.

U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07399470) titled 'A Clinical Study in Healthy Adults to See How the Body Processes and How Safe a Tablet That Combines Gemigliptin, Dapagliflozin, and Metformin is, Compared With Taking Zemiglo and Xigduo XR Together While Fasting.' on Jan. 23.

Brief Summary: Bioequivalence study for the fixed-dose combination of Gemigliptin/Dapagliflozin/Metformin 50/10/1000 mg under fasting conditions in healthy volunteers

Study Start Date: Jan. 09

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers Fasting Conditions

Intervention: DRUG: Test drug: Fixed-dose combination of gemigliptin/dapagliflozin/metformin 50/10/1000 mg

All participants will take 1 t...